GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » EPS (Diluted)

CMIC HOLDINGS Co (TSE:2309) EPS (Diluted) : 円307.99 (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co EPS (Diluted)?

CMIC HOLDINGS Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円7.40. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円307.99.

CMIC HOLDINGS Co's EPS (Basic) for the three months ended in Dec. 2023 was 円7.40. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円307.99.

CMIC HOLDINGS Co's EPS without NRI for the three months ended in Dec. 2023 was 円7.59. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円256.34.

During the past 12 months, CMIC HOLDINGS Co's average EPS without NRIGrowth Rate was -35.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 29.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 32.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, CMIC HOLDINGS Co's highest 3-Year average EPS without NRI Growth Rate was 51.50% per year. The lowest was -21.40% per year. And the median was 21.70% per year.


CMIC HOLDINGS Co EPS (Diluted) Historical Data

The historical data trend for CMIC HOLDINGS Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co EPS (Diluted) Chart

CMIC HOLDINGS Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.82 83.19 111.83 477.72 423.58

CMIC HOLDINGS Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.70 265.28 63.97 -28.67 7.40

Competitive Comparison of CMIC HOLDINGS Co's EPS (Diluted)

For the Diagnostics & Research subindustry, CMIC HOLDINGS Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CMIC HOLDINGS Co's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CMIC HOLDINGS Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where CMIC HOLDINGS Co's PE Ratio falls into.



CMIC HOLDINGS Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

CMIC HOLDINGS Co's Diluted EPS for the fiscal year that ended in Sep. 2023 is calculated as

Diluted EPS (A: Sep. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(7152-0)/16.885
=423.57

CMIC HOLDINGS Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(125-0)/16.885
=7.40

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円307.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CMIC HOLDINGS Co  (TSE:2309) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CMIC HOLDINGS Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


CMIC HOLDINGS Co (TSE:2309) Business Description

Traded in Other Exchanges
N/A
Address
Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines